Lakeridge Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Buy
6,234
+65
+1% +$15.1K 0.58% 37
2026
Q1
$1.51M Sell
6,169
-44
-0.7% -$10.2K 0.65% 37
2025
Q4
$1.29M Buy
6,213
+79
+1% +$15.6K 0.58% 38
2025
Q3
$1.14M Sell
6,134
-105
-2% -$18K 0.51% 38
2025
Q2
$953K Sell
6,239
-436
-7% -$67K 0.44% 39
2025
Q1
$1.11M Sell
6,675
-437
-6% -$68.4K 0.55% 34
2024
Q4
$1.03M Sell
7,112
-215
-3% -$33.3K 0.53% 36
2024
Q3
$1.19M Sell
7,327
-73
-1% -$11.6K 0.65% 30
2024
Q2
$1.08M Buy
7,400
+371
+5% +$55.2K 0.65% 30
2024
Q1
$1.11M Sell
7,029
-758
-10% -$121K 0.72% 27
2023
Q4
$1.22M Buy
+7,787
New +$1.19M 0.88% 25

Other funds holding JNJ

Lakeridge Wealth Management's JNJ Position: Q2 2026 in Review

Lakeridge Wealth Management increased its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, buying an estimated $15.1K and bringing the position to 6,234 shares worth $1.58M. The position accounts for 0.58% of the portfolio, ranked #37.

Lakeridge Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lakeridge Wealth Management held 6,234 shares of Johnson & Johnson worth $1.58M as of Q2 2026.
  • Lakeridge Wealth Management bought 65 Johnson & Johnson shares in Q2 2026, an estimated $15.1K.
  • Johnson & Johnson made up 0.58% of Lakeridge Wealth Management's portfolio in Q2 2026, its #37 holding.
  • Lakeridge Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lakeridge Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.